Nazofan-Teva nasal spray 50mcg/dose 120doz №1

Name:
Nazofan. Release form: Dosed nasal spray. Dosage 50 mcg / 1 dose 120 doses. Qty per package: 1 pc. Manufacturer Teva. INN Fluticasone. FTGglucocorticosteroid for local use. Composition Active ingredient: fluticasone propionate 50 mcg/dose Auxiliary ingredients: polysorbate 80, microcrystalline cellulose, anhydrous glucose, benzalkonium chloride solution 50%, phenylethyl alcohol, purified water
Description:
Homogeneous suspension from white to grayish-white color. Pharmacological action It has anti-inflammatory, anti-allergic, anti-edematous action. The anti-inflammatory effect is realized as a result of the interaction of the drug with GCS receptors. Suppresses the proliferation of mast cells, eosinophils, lymphocytes, macrophages, neutrophils. Fluticasone propionate reduces the production of inflammatory mediators and other biologically active substances (histamine, PG, leukotrienes, cytokines) during the early and late phases of an allergic reaction. Restores the patient’s response to bronchodilators, allowing to reduce the frequency of their use. Reduces sneezing, nasal itching, runny nose, nasal congestion, sinus discomfort and pressure around the nose and eyes. It also relieves eye symptoms associated with allergic rhinitis. Indications for use Prevention and treatment of seasonal allergic rhinitis (including hay fever) and perennial rhinitis. Contraindications Hypersensitivity to fluticasone propionate or other ingredients of the drug. Pregnancy and lactation. Chronic atrophic rhinitis, children under 4 years of age. Route of administration and dosesNazofan is intended for intranasal administration only. Before the first use of Nasofan, the vial must be brought to readiness by pressing and releasing the pump 6 times. If the spray has not been used for 7 days, it is brought to readiness by pressing and releasing the pump a sufficient number of times until a thick spray appears. Do not use the drug 3 months after the first use. Adults and children over 12 years of age The recommended dose is 2 irrigations in each nostril once a day (200 mcg), preferably in the morning. In some cases, the dose may be 2 irrigations in each nostril 2 times a day (400 mcg). After achieving a therapeutic effect, it is possible to use a maintenance dose – 1 irrigation in each nostril 1 time per day (100 mcg). If the symptoms of the disease reappear, the dose may be increased accordingly. The maximum daily dose should not exceed 4 irrigations in each nostril (400 mcg). The minimum dose sufficient to obtain a therapeutic effect should be used. Elderly Patients Usual adult dosage is used. Children aged 4-12 years The recommended dose is 1 irrigation in each nostril 1 time per day (100 mcg), preferably in the morning. In some cases, the dose may be 1 irrigation in each nostril 2 times a day (200 mcg). The maximum daily dose should not exceed 2 irrigations in each nostril (200 mcg). The lowest dose sufficient to effectively control symptoms should be used. Children under 4 years of age: Since there are no sufficient data on the safety and efficacy of Nazofan in children under 4 years of age, it is not recommended to use the drug in patients of this age group. To achieve a greater therapeutic effect, the drug must be used regularly. The lack of an immediate effect is explained by the fact that maximum relief can be achieved no earlier than 3-4 days from the start of treatment. Side effects Probable side reactions and their frequency are given in the table. The frequency is defined as: very often (>1/10), often (>1/100 and <1/10), sometimes (>1/1000 and <1/100), rarely (>1/10000 and <1/100). 1000) and very rarely (<1/10,000), including data from individual reports. With prolonged use of intranasal corticosteroids, especially at high doses, systemic effects may occur. If any of these side effects occur, contact your doctor immediately. In case of any unusual reactions, be sure to consult your doctor about the further use of the drug! Overdose Cases of acute or chronic overdose of Nazofan have not been reported. Intranasal administration of 2 mg of fluticasone propionate 2 times a day for 7 weeks in healthy volunteers had no effect on adrenal function. Inhalation or oral use of corticosteroids in high doses for a long time can cause hypothalamic-pituitary-adrenal depression. Interaction with other drugs Experimental studies did not reveal any significant effect of fluticasone on the pharmacokinetics of terfenadine and erythromycin. The effect of terfenadine on the pharmacokinetics of fluticasone was also insignificant. Fluticasone propionate is used with caution in combination with potent inhibitors of the cytochrome P450 ZA4 system (for example, protease inhibitors such as ritonavir). The simultaneous use of fluticasone propionate and 100 mg of ritonavir (a potent inhibitor of the cytochrome P450 ZA4 system) 2 times a day increased the concentration of fluticasone propionate in the blood plasma hundreds of times, which was the cause of a marked decrease in the concentration of cortisol in the blood serum. Cushing's syndrome and adrenal suppression have been reported. The use of such a combination should be avoided, unless the expected benefit outweighs the potential risk of systemic side effects of corticosteroids. Other inhibitors of the cytochrome P450 3A4 system cause a very slight (erythromycin) and a slight (ketoconazole) increase in the systemic effect of fluticasone propionate without a noticeable decrease in the concentration of cortisol in the blood serum. If you are taking any other medicines, be sure to inform your doctor! Do not take any other medicines (including those available without a prescription) while you are being treated with Nazofan without first talking to your doctor. Uncontrolled treatment can harm your health! Release form A yellow glass bottle equipped with a dosing device, a white nasal adapter and a transparent protective cap containing 120 doses of the drug, together with a leaflet in a cardboard box. Storage conditions Store in the original packaging at temperatures up to +25 ° C, out of the reach of children. Shelf life 3 years from the date of production 3 months from the moment the bottle is opened Do not use after the expiration date indicated on the package. Terms of dispensing from pharmacies By prescription. Buy Nasophane-Teva nasal spray 50mcg/dose 120doz No. 1 Price for Nasophane-Teva nasal spray 50mcg/dose 120dose No. 1